“Our most valuable resources are our children and our environment, and Pfizer seeks to protect both by ensuring that our products for infants and children are manufactured to the most rigorous of safety and quality standards, with minimal environmental impact.”, “Infant Formula is one of the most stringently regulated consumer products in the world,” said Natale Ricciardi, senior vice president of Pfizer and president of Pfizer Global Manufacturing. Over 50% of water used by the plant for maintenance purposes is recycled. INDIANAPOLIS (AP) -- Pfizer Inc., the world's biggest drugmaker, said Thursday it invested $100 million in the expansion of its Singapore plant that makes nutritional products for infants and children. Number 8860726. (BUSINESS WIRE)--Pfizer Inc. today announced a $100 million (U.S.) investment into the expansion of its Singapore Nutrition Plant, helping it continue to set the standard for the manufacture of high-quality, safe and environmentally sustainable nutritional products for infants and children.

As part of the plant expansion, Pfizer has added over 100 new positions in the past year, bringing its staff strength to 587 people in total. )--Pfizer Inc. today announced a $100 million (U.S.) investment into the expansion of its Singapore Nutrition Plant, helping it continue to set the standard for the manufacture of high-quality, safe and environmentally sustainable nutritional products for infants and children. Investor:

This expansion, which brings the total investment in the plant to $372 million (U.S.), makes it one of the largest nutritional plants worldwide. To learn more about our commitments, please visit us at www.pfizer.com. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. “The expansion of our Singapore Nutrition Plant is one example of Pfizer’s commitment to securing a healthy and sustainable future for our children,” said Jeffrey B. Kindler, chairman and chief executive officer of Pfizer.

OR £10 PER MONTH FOR ALL CONTENT ON CERTAIN TOPICS. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
Please read our privacy policy for more details. A description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K. Media:
"Pfizer's expansion today marks another significant milestone in the long-standing Pfizer-Singapore partnership. GNC completes sale to Chinese shareholder Harbin, 5@5: New additive combats dicamba drift | Topical CBD sales outpace edibles, General Mills encourages farmers to embrace a 'regenerative mindset', Kroger expands private-label plant-based product selection, Unboxed: Flavors, functions and formats adding buzz to the coffee category, Unboxed: 5 organic brands that help put the 'cool' back in the freezer aisle, NFM New Product Showcase - September/October 2020, Allowed HTML tags:

. "Our most valuable resources are our children and our environment, and Pfizer seeks to protect both by ensuring that our products for infants and children are manufactured to the most rigorous of safety and quality standards, with minimal environmental impact. This website uses cookies to improve your experience. Energy Efficient Expansion Creates More Than 100 Jobs and Increases Production Capacity by 50 Percent.

Web page addresses and e-mail addresses turn into links automatically.

We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. The Pfizer Singapore Nutritional Plant achieves sustainability through the use of advanced technology aimed at maximizing energy efficiency and reducing waste. (65) 8322 4178[email protected] NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced today that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to approximately 44,000 participants which also allows for the enrollment of new populations.

The expansion was completed in June 2010. All rights reserved.

We have over 1,200 employees, with more than 10 groups operating in Singapore. We have over 1,200 employees, with more than 10 groups operating in Singapore. Pfizer’s expansion is the second big biotech jobs announcement in recent weeks, following Merck’s decision to add more than 400 jobs in Durham and Wilson.

This release contains forward-looking information about the potential benefits of the expansion of the Singapore Nutrition Plant, that involves substantial risks and uncertainties. Today's expansion also attests to Pfizer's continued confidence in Singapore as a location for global manufacturing excellence and business hub in the heart of dynamic Asia," said Mr. Lim Hng Kiang, minister for Trade&Industry, Singapore.

Today’s expansion also attests to Pfizer’s continued confidence in Singapore as a location for global manufacturing excellence and business hub in the heart of dynamic Asia,” said Mr. Lim Hng Kiang, minister for Trade & Industry, Singapore.

For more than 150 years, Pfizer has worked to make a difference for all who rely on us. PFIZER DISCLOSURE NOTICE: The information contained in this release is as of July 7, 2010. Engineering and construction services for Pfizer’s facility in Singapore In January 2001, Jacobs Engineering Group announced that Jacobs Lend Lease contracted with Pfizer to provide engineering and construction services for the new facility.